Trials / Completed
CompletedNCT01040325
Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study
A Phase Two, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System in Travelers to Asia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 723 (actual)
- Sponsor
- Intercell USA, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the efficacy of the TD Vaccine System to prevent moderate to severe enterotoxin E.coli (ETEC) disease in travelers to India.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | TD Vaccine System | TD Vaccine System containing heat labile enterotoxin of E. coli (LT) |
| BIOLOGICAL | TD Vaccine System | TD Vaccine System Containing Placebo Product |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-06-01
- Completion
- 2010-12-01
- First posted
- 2009-12-29
- Last updated
- 2012-03-14
Locations
12 sites across 3 countries: Germany, India, United Kingdom
Source: ClinicalTrials.gov record NCT01040325. Inclusion in this directory is not an endorsement.